Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nolan Vale"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/9d963771294247dc8daf53743558ee3e
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/5d5f60e3d0864f85915507f3c5531a6c
Autor:
Amy R. Copeland, Mackenzie L. Shindorf, Lien T. Ngo, Jared J. Gartner, Noam Levin, Steven A. Rosenberg, Rami Yossef, Maria R. Parkhurst, Nolan Vale, Frank J. Lowery, Sang-hyun Kim, Satyajit Ray, Biman C. Paria, Zhiya Yu, Paul F. Robbins, Gal Cafri, Maria Florentin
Publikováno v:
Clinical Cancer Research. 27:5084-5095
Purpose: Immunotherapies mediate the regression of human tumors through recognition of tumor antigens by immune cells that trigger an immune response. Mutations in the RAS oncogenes occur in about 30% of all patients with cancer. These mutations play
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d9944ec18103e147cbc1b389a458ea7
https://doi.org/10.1158/1078-0432.ccr-21-0849
https://doi.org/10.1158/1078-0432.ccr-21-0849
Autor:
Steven A. Rosenberg, Zhili Zheng, Yong-Chen Lu, Chuong D. Hoang, Billel Gasmi, Stephanie L. Goff, Paul D. Robbins, Biman C. Paria, Maria R. Parkhurst, Yong Li, Jonathan M. Hernandez, Praveen D. Chatani, Samantha Seitter, Sang-hyun Kim, Drew C. Deniger, Nolan Vale, Maria Florentin, Frank J. Lowery, Sri Krishna, Todd D. Prickett, Sivasish Sindiri, Shoshana Levi, Noam Levin, Victoria Hill, Zhiya Yu, Parisa Malekzadeh, Li Jia, Agnes Y Choi, Elizabeth A. Hedges, Lien Ngo, Jared J. Gartner, Richard M. Sherry, Nikolaos Zacharakis, Satyajit Ray, James Chih-Hsin Yang
Adoptive cell therapy (ACT) targeting neoantigens can achieve durable clinical responses in patients with cancer. Most neoantigens arise from rare mutations, requiring highly individualized treatments. To broaden the applicability of ACT targeting ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cba76f22dc2427922bcf92666b5e7cbc
https://doi.org/10.21203/rs.3.rs-916555/v1
https://doi.org/10.21203/rs.3.rs-916555/v1
Autor:
Elizabeth Hedges, Peter S. Kim, Nolan Vale, Nikolaos Zacharakis, Steven A. Rosenberg, Parisa Malekzadeh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Adoptive cell therapies (ACT) directed against the products of somatic mutations in cancer cells can lead to long lasting clinical responses. We focused on ACT against shared p53 mutations to be used to potentially treat a broad range of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3071e7ed97891bfad52f8c22cd707493
https://doi.org/10.1136/jitc-2020-sitc2020.0152
https://doi.org/10.1136/jitc-2020-sitc2020.0152